Effectiveness of a VAP Prevention Bundle in the PICU

NCT03763695 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 242

Last updated 2018-12-04

No results posted yet for this study

Summary

This observational monocentric prospective study aims to evaluate the efficacy of new measures for ventilator associated pneumonia (VAP) management in the pediatric population in the pediatric intensive care unit (PICU) of Fondazione Policlinico Agostino Gemelli of 8 beds. The investigators will compare the incidence of VAP in the group of patients in which this protocol has been implemented to a retrospective control group of patients before the new protocol implementation. VAP bundle includes oral care hygiene measures (i.e chlorhexidine swab), to keep clean and dry ventilator circuits and head positioning at 45 degrees.

Conditions

  • Ventilator Associated Pneumonia

Interventions

OTHER

Measures for the VAP prevention in the PICU

Oral hygiene care (i.e chlorhexidine swab); clean and dry ventilator circuits; head positioning at 45 degrees.

OTHER

Evaluation of VAP incidence before the protocol introduction

evaluation of VAP incidence in our pediatric population of intensive care patients before the implementation of the protocol for VAP prevention

Sponsors & Collaborators

  • Ilaria Vitali

    collaborator UNKNOWN
  • Antonio Maria Dell Anna

    collaborator UNKNOWN
  • Leonardo Dassatti

    collaborator UNKNOWN
  • Giuseppe Bello

    collaborator UNKNOWN
  • Giorgio Conti

    collaborator UNKNOWN
  • Antonio D Addona

    collaborator UNKNOWN
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Principal Investigators

  • Giorgio Conti, MD · Università Cattolica del Sacro Cuore; Fondazione Policlinico Universitario Agostino Gemelli; IRCCS

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-12-31
Completion
2020-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03763695 on ClinicalTrials.gov